Paula Fraenkel is an Oncology physician affiliated with AstraZeneca. OpenAlex indexes 75 publications with 1,544 citations (h-index 18).
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingNIH funding
2 NIH research awards on record, funded 2002–2015 per NIH RePORTER. The latest:
- Modifiers of hepcidin expression as new therapies for iron overload
Beth Israel Deaconess Medical Center
FY2015$377,580R01DK085250 - Modifiers of hepcidin expression as new therapies for iron overload
Beth Israel Deaconess Medical Center
FY2014$377,580R01DK085250 - Modifiers of hepcidin expression as new therapies for iron overload
Beth Israel Deaconess Medical Center
FY2013$364,365R01DK085250
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Carl June, MD
University of Pennsylvania
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
Beth Karlan, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”